ATYR-4010

N/A

Report date: 2023/12/14 17:30:32

Base Information

Drug NameATYR-4010
Drug Alias NameATYR-4010ATYR4010
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionNeuropilin 2 antagonistsC-C chemokine receptor type 7 antagonists
TargetsNeuropilin 2C-C chemokine receptor type 7
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAtyr Pharma
China Registration ClassN/A

Develop Information

Active CompaniesAtyr Pharma Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A